Combination treatment may be valuable therapeutic option for HER2-negative metastatic

[News]

Finding the ideal combination of targeted, hormonal and chemotherapeutic agents to treat HER2-negative metastatic breast cancer has been challenging researchers for decades.

More... (http://www.news-medical.net/news/20161201/Combination-treatment-may-be-valuable-therapeutic-option-for-HER2-negative-metastatic-breast-cancer.aspx)